Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Thyrotoxicosis: Diagnosis and Management.

Sharma A, Stan MN.

Mayo Clin Proc. 2019 Mar 25. pii: S0025-6196(18)30799-7. doi: 10.1016/j.mayocp.2018.10.011. [Epub ahead of print] Review.

PMID:
30922695
2.

Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series.

Kotwal A, Turcu AF, Sonawane V, Bahn RS, Pittelkow MR, Bridges A, Stan MN.

Thyroid. 2019 May;29(5):692-699. doi: 10.1089/thy.2018.0706. Epub 2019 Apr 8.

PMID:
30854936
3.

Current and Emerging Treatment Strategies for Graves' Orbitopathy.

Genere N, Stan MN.

Drugs. 2019 Feb;79(2):109-124. doi: 10.1007/s40265-018-1045-9. Review.

PMID:
30659423
4.

In Reply-Ethanol Ablation of Cystic Thyroid Nodules.

Castro MR, Iniguez-Ariza NM, Lee RA, Singh-Ospina NM, Stan MN.

Mayo Clin Proc. 2019 Jan;94(1):171. doi: 10.1016/j.mayocp.2018.10.003. No abstract available.

PMID:
30611445
5.

Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience.

Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN.

J Endocr Soc. 2018 Sep 6;2(11):1226-1235. doi: 10.1210/js.2018-00259. eCollection 2018 Nov 1.

6.

Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy.

Kotwal A, Stan M.

Horm Metab Res. 2018 Dec;50(12):871-886. doi: 10.1055/a-0739-8134. Epub 2018 Oct 4. Review.

PMID:
30286486
7.

In Reply-Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules.

Hamidi O, Callstrom MR, Lee RA, Dean D, Castro MR, Morris JC 3rd, Stan MN.

Mayo Clin Proc. 2018 Sep;93(9):1328-1329. doi: 10.1016/j.mayocp.2018.05.006. No abstract available.

PMID:
30193678
8.

Ethanol Ablation for the Treatment of Cystic and Predominantly Cystic Thyroid Nodules.

Iñiguez-Ariza NM, Lee RA, Singh-Ospina NM, Stan MN, Castro MR.

Mayo Clin Proc. 2018 Aug;93(8):1009-1017. doi: 10.1016/j.mayocp.2018.05.020. Epub 2018 Jul 4.

PMID:
30078409
9.

Thyrotropin Receptor Antibodies-An Overview.

Kotwal A, Stan M.

Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S20-S27. doi: 10.1097/IOP.0000000000001052. Review.

PMID:
29771756
10.

Failing Kidneys and Thyroid Dysfunction-An Undesirable Synergy.

Stan MN, Drake MT.

Mayo Clin Proc. 2018 May;93(5):555-557. doi: 10.1016/j.mayocp.2018.03.027. No abstract available.

PMID:
29728198
11.

Graves' disease-induced complete heart block and asystole.

El-Harasis MA, DeSimone CV, Stan MN, McLeod CJ, Noseworthy PA.

HeartRhythm Case Rep. 2017 Dec 29;4(3):105-108. doi: 10.1016/j.hrcr.2017.12.001. eCollection 2018 Mar. No abstract available.

12.

Outcomes of Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules: A Mayo Clinic Case Series.

Hamidi O, Callstrom MR, Lee RA, Dean D, Castro MR, Morris JC, Stan MN.

Mayo Clin Proc. 2018 Aug;93(8):1018-1025. doi: 10.1016/j.mayocp.2017.12.011. Epub 2018 Mar 21.

PMID:
29572016
13.

Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes.

Farhadfar N, Stan MN, Shah P, Sonawane V, Hefazi MT, Murthy HS, Zou F, Sican X, Hashmi SK.

Bone Marrow Transplant. 2018 Aug;53(8):977-982. doi: 10.1038/s41409-018-0109-5. Epub 2018 Feb 6.

PMID:
29410547
14.

The Structure of Liquid and Amorphous Hafnia.

Gallington LC, Ghadar Y, Skinner LB, Weber JKR, Ushakov SV, Navrotsky A, Vazquez-Mayagoitia A, Neuefeind JC, Stan M, Low JJ, Benmore CJ.

Materials (Basel). 2017 Nov 10;10(11). pii: E1290. doi: 10.3390/ma10111290.

15.

Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer.

Iñiguez-Ariza NM, Stan MN, Bible KC.

Endocrine. 2018 Jan;59(1):228-229. doi: 10.1007/s12020-017-1464-5. Epub 2017 Nov 1. No abstract available.

PMID:
29094258
16.

Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment.

Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, De Ycaza AE, Rodriguez-Gutierrez R, Coddington CC 3rd, Stan MN, Brito JP, Montori VM.

BMJ. 2017 Jan 25;356:i6865. doi: 10.1136/bmj.i6865.

17.

Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.

Sundaresh V, Brito JP, Thapa P, Bahn RS, Stan MN.

Thyroid. 2017 Apr;27(4):497-505. doi: 10.1089/thy.2016.0343. Epub 2017 Feb 6.

18.

Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study.

Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC, Stan MN.

Thyroid. 2016 Nov;26(11):1598-1604. Epub 2016 Oct 5.

19.

MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials.

Stan MN, Salvi M.

Eur J Endocrinol. 2017 Feb;176(2):R101-R109. Epub 2016 Oct 19. Review.

PMID:
27760790
20.

Riedel's thyroiditis association with IgG4-related disease.

Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS.

Clin Endocrinol (Oxf). 2017 Mar;86(3):425-430. doi: 10.1111/cen.13238. Epub 2016 Oct 7.

PMID:
27647429

Supplemental Content

Loading ...
Support Center